Kuss, Oliver http://orcid.org/0000-0003-3301-5869
Rathmann, Wolfgang
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Accepted: 8 March 2023
First Online: 15 April 2023
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. The German Diabetes Center is supported by the Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (Ministry of Culture and Science of the State of North Rhine-Westphalia, Düsseldorf, Germany) and the Bundesministerium für Gesundheit (Federal Ministry of Health, Bonn/Berlin, Germany).
: Oliver Kuss has received honoraria for biostatistical education from Berlin-Chemie. Wolfgang Rathmann has received consulting fees from AstraZeneca, Boehringer Ingelheim and NovoNordisk for attending educational sessions or advisory boards, and institutional research grants from NovoNordisk, outside the topic of this work. Both authors have noted the journal’s policy on competing interests and confirm that they have reported all interests that could impart bias on the submitted work.
: This work only includes aggregated data that were published in the original work of Alkabbani et al. on which this comment is based. Therefore, ethics approval was not applicable and was not applied for.
: Not applicable.
: Not applicable.
: The full data set is reported in the Appendix
: The full SAS analysis code is reported in the Appendix.
: OK conceived the initial idea for this letter, performed the statistical analysis, and wrote the first draft of the paper. WR is the guarantor for the clinical content, commented on the analysis, and reworked the initial draft. Both authors have read and approved the final version of this letter.